Virginia G. De Yebenes
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL.
Journal: Leukemia
Published: October 06, 2025
Restricting SLC7A5-mediated Leucine uptake in T cells prevents acute GVHD and maintains GVT response.
Journal: EMBO molecular medicine
Published: February 05, 2024
MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.
Journal: Oncogene
Published: February 01, 2023
miR-28-based combination therapy impairs aggressive B cell lymphoma growth by rewiring DNA replication.
Journal: Cell death & disease
Published: November 30, 2022
microRNA Fine-Tuning of the Germinal Center Response.
Journal: Frontiers in immunology
Published: January 29, 2021
Aging-Associated miR-217 Aggravates Atherosclerosis and Promotes Cardiovascular Dysfunction.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: August 28, 2020
Interplay between UNG and AID governs intratumoral heterogeneity in mature B cell lymphoma.
Journal: PLoS genetics
Published: June 23, 2020
miRNA-Based Therapies in B Cell Non-Hodgkin Lymphoma.
Journal: Trends in immunology
Published: June 15, 2020
Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL.
Journal: Leukemia
Published: October 02, 2019
A broad atlas of somatic hypermutation allows prediction of activation-induced deaminase targets.
Journal: The Journal of experimental medicine
Published: September 20, 2017
Last Updated: 09/26/2026